This Article Order Full text via Infotrieve Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bowes, M. P. Articles by Zivin, J. A. Search for Related Content PubMed PubMed Citation Articles by Bowes, M. P. Articles by Zivin, J. A.

Stroke, Vol 25, 2253-2257, Copyright © 1994 by American Heart Association

ARTICLES

Diaspirin cross-linked hemoglobin improves neurological outcome following reversible but not irreversible CNS ischemia in rabbits

MP Bowes, KE Burhop and JA Zivin
Department of Neurosciences, School of Medicine, University of California San Diego, La Jolla 92093-0624.

BACKGROUND AND PURPOSE: Hemodilution using modified hemoglobin solutions may reduce ischemic central nervous system injury. Purified diaspirin cross-linked hemoglobin (DCLHb) is a cell-free hemoglobin that is intramolecularly cross-linked between the two alpha subunits, resulting in enhanced oxygen offloading to tissues and increased half- life. In the present experiments, we evaluated the ability of DCLHb to reduce neurological damage in two rabbit stroke models. METHODS: In a reversible spinal cord ischemia model, ischemia of the caudal lumbar spinal cord was produced by temporary occlusion of the abdominal aorta. In an irreversible model of cerebral ischemia, plastic microspheres (50 microns) were injected into the internal carotid artery and lodged in the cerebral microvasculature. DCLHb was administered 5 minutes after initiation of ischemia as either a 10-mL/kg infusion, 10-mL/kg exchange transfusion, or a 20-mL/kg infusion. Control animals received human serum albumin that was oncotically matched to the DCLHb. RESULTS: In the spinal cord model, DCLHb significantly increased the duration of ischemia required to produce permanent paralysis from 27.33 +/- 8.71 minutes (mean +/- SD) in controls to 42.59 +/- 10.10 minutes in the 10- mL/kg exchange transfusion group and to 40.82 +/- 18.16 minutes in the 20-mL/kg infusion condition (P < .05). DCLHb did not significantly reduce neurological damage in the microsphere embolization model. CONCLUSIONS: These data suggest that cross-linked hemoglobin reduces neurological damage after reversible central nervous system ischemia and that this is not attributable to hemodilution or hypervolemia only.

This article has been cited by other articles:

				A. T. Kawaguchi, D. Fukumoto, M. Haida, Y. Ogata, M. Yamano, and H. Tsukada Liposome-Encapsulated Hemoglobin Reduces the Size of Cerebral Infarction in the Rat: Evaluation With Photochemically Induced Thrombosis of the Middle Cerebral Artery Stroke, May 1, 2007; 38(5): 1626 - 1632. [Abstract] [Full Text] [PDF]

				M. Davis and D. Barer Neuroprotection in acute ischaemic stroke. II: Clinical potential Vascular Medicine, August 1, 1999; 4(3): 149 - 163. [Abstract] [PDF]

				R. Saxena, A. D. Wijnhoud, H. Carton, W. Hacke, M. Kaste, R. J. Przybelski, K. N. Stern, and P. J. Koudstaal Controlled Safety Study of a Hemoglobin-Based Oxygen Carrier, DCLHb, in Acute Ischemic Stroke Stroke, May 1, 1999; 30(5): 993 - 996. [Abstract] [Full Text] [PDF]

				H. P. Grocott, R. D. Bart, H. Sheng, Y. Miura, R. Steffen, R. D. Pearlstein, D. S. Warner, and E. P. Wei Effects of a Synthetic Allosteric Modifier of Hemoglobin Oxygen Affinity on Outcome From Global Cerebral Ischemia in the Rat • Editorial Comment Stroke, August 1, 1998; 29(8): 1650 - 1655. [Abstract] [Full Text] [PDF]

				J. Aronowski, R. Strong, J.C. Grotta, and H. A. Kontos Combined Neuroprotection and Reperfusion Therapy for Stroke: Effect of Lubeluzole and Diaspirin Cross-Linked Hemoglobin in Experimental Focal Ischemia Stroke, September 1, 1996; 27(9): 1571 - 1577. [Abstract] [Full Text]

				A. Rebel, J. A. Ulatowski, K. Joung, E. Bucci, R. J. Traystman, and R. C. Koehler Regional cerebral blood flow in cats with cross-linked hemoglobin transfusion during focal cerebral ischemia Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H832 - H841. [Abstract] [Full Text] [PDF]